Aspects of laboratory characteristics, analysis of alloimmunization, and searching for predictors related to survival in patients with Autoimmune Hemolytic Anemia
Autoimmune hemolytic anemia (AIHA) is characterized by hemolysis caused by autoantibodies. However, many patients do not respond to therapies and may have an unfavorable outcome. It has been hypothesized that patients with AIHA and alloantibodies have a lower survival compared to patients with this disease and without alloimmunization. To this end, the clinical and laboratory profile was described and sought to identify features associated with survival in patients with AIHA. This is a single-site retrospective observational study that included patients (children, adolescents, adults and elderly) diagnosed with AIHA from January 2000 to June 2019.
Source: Transfusion and Apheresis Science - Category: Hematology Authors: Giane Durigon, Leo Sekine, Juliana Pires Marafon Franz, Laura Maria Fogliatto, Lucia Mariano da Rocha Silla Source Type: research
More News: Anemia | Autoimmune Disease | Children | Hematology | Laboratory Medicine | Science | Study